[{"data":1,"prerenderedAt":246},["ShallowReactive",2],{"options:asyncdata:$edqCtX92v0:/blogs/nci-k-ceo-dr-elias-melly-delivers-keynote-address-at-international-cancer-registries-conference-in-tanzania:0":3},{"blogPost":4,"otherBlogs":79},{"id":5,"date":6,"date_gmt":6,"guid":7,"modified":9,"modified_gmt":9,"slug":10,"status":11,"type":12,"link":13,"title":14,"content":16,"excerpt":19,"author":21,"featured_media":22,"comment_status":23,"ping_status":23,"sticky":18,"template":20,"format":24,"meta":25,"categories":27,"tags":28,"class_list":29,"featured_media_src_url":36,"_links":37},739,"2026-10-16T05:02:06",{"rendered":8},"https://wp.ncikenya.go.ke/?p=739","2026-10-17T07:02:56","nci-k-ceo-dr-elias-melly-delivers-keynote-address-at-international-cancer-registries-conference-in-tanzania","publish","post","https://wp.ncikenya.go.ke/2026/10/16/nci-k-ceo-dr-elias-melly-delivers-keynote-address-at-international-cancer-registries-conference-in-tanzania/",{"rendered":15},"NCI-K CEO Dr. Elias Melly Delivers Keynote Address at International Cancer Registries Conference in Tanzania",{"rendered":17,"protected":18},"\n\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Arusha, Tanzania | 14–16 October 2026\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The Chief Executive Officer of the National Cancer Institute of Kenya (NCI-K), Dr. Elias Melly, delivered a keynote address at the IACR–AFCRN–NORA Scientific Conference held at Mount Meru Hotel in Arusha, Tanzania, from 14 to 16 October 2026.\u003C/p>\n\n\n\n\u003Cfigure class=\"wp-block-image size-large\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"768\" src=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/10/818761-1024x768.jpg\" alt=\"\" class=\"wp-image-740\" srcset=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/10/818761-1024x768.jpg 1024w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/10/818761-300x225.jpg 300w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/10/818761-768x576.jpg 768w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/10/818761-1536x1152.jpg 1536w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/10/818761.jpg 1600w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" />\u003C/figure>\n\n\n\n\u003Cp class=\"has-text-align-center wp-block-paragraph\">\u003Cem>NCI-K CEO, Dr. Elias Melly Delivery his Keynote Address at the IACR, Tanzania.\u003C/em>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Dr. Melly was featured as the keynote speaker on the opening day of the conference, on 14 October 2026, underscoring Kenya’s participation in regional and international efforts to strengthen cancer prevention and control through research, reliable cancer data and effective surveillance systems.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The scientific conference brought together cancer registry professionals, researchers and public health experts to share scientific evidence, exchange knowledge and discuss approaches to improving cancer registration, surveillance, research and the use of cancer data to inform policy and public health interventions.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Strengthening Regional and International Partnerships in Cancer Control\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The conference provided a platform for collaboration among the International Association of Cancer Registries (IACR), the African Cancer Registry Network (AFCRN) and NORA, alongside scientific sessions involving NORA–REACCT–CAN. These collaborative platforms brought together expertise and research from across Africa and other regions to address shared challenges in cancer registration and control.\u003C/p>\n\n\n\n\u003Cfigure class=\"wp-block-image size-large\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"1024\" src=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/10/818758-768x1024-1.jpg\" alt=\"\" class=\"wp-image-741\" srcset=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/10/818758-768x1024-1.jpg 768w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/10/818758-1152x1536.jpg 1152w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/10/818758.jpg 1200w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" />\u003C/figure>\n\n\n\n\u003Cp class=\"has-text-align-center wp-block-paragraph\">\u003Cem>Dr. Melly (centre)with outgoing IACR President, Dr. Charles Wiggins (right), and the incoming president, Dr. Dabber Wanna (left)\u003C/em>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">For NCI-K, participation in such regional and international scientific engagements reinforces the importance of partnerships in strengthening cancer surveillance, building institutional capacity and generating evidence to guide national cancer control priorities.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Effective cancer control depends on access to quality, timely and reliable data on cancer incidence, mortality, survival and patterns of diagnosis. Strong cancer registration systems help governments and health institutions understand the burden of cancer, identify gaps in services, plan interventions and assess progress in prevention, early detection, treatment and care.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The conference programme featured discussions on population-based cancer registration, cancer registry governance and standards, data quality and accessibility, cervical cancer screening, cancer survival, and translating registry data into policy and public health action.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Kenya Advances National Childhood Cancer Registry Development\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Kenya’s contribution to the scientific programme also featured work towards strengthening childhood cancer surveillance. On 15 October 2026, Gladys Chesumbai, Head of the National Cancer Registry at the National Cancer Institute of Kenya presented on “Delphi Consensus for a Standardized National Childhood Cancer Registry Minimum Dataset in Kenya.”\u003C/p>\n\n\n\n\u003Cfigure class=\"wp-block-image size-large\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"1024\" src=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/10/818752-768x1024-1.jpg\" alt=\"\" class=\"wp-image-742\" srcset=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/10/818752-768x1024-1.jpg 768w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/10/818752-225x300.jpg 225w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/10/818752-1152x1536.jpg 1152w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/10/818752.jpg 1200w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" />\u003C/figure>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cem>Gladys Chesumbai, Head of Cancer Registry at NCI-K\u003C/em>.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The presentation formed part of a plenary session examining the burden of childhood, adolescent and early-onset cancers. Standardising the minimum dataset for a national childhood cancer registry is an important area of work in strengthening the consistency and quality of information collected on childhood cancers.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Reliable childhood cancer data can support a better understanding of the disease burden, inform research and planning, and provide an evidence base for decisions aimed at improving services for children affected by cancer.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Kenya’s participation in this scientific exchange highlights the value of sharing national experiences and learning from international expertise as the country advances its cancer surveillance and registry development agenda.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Advancing the National Cancer Control Agenda Through Collaboration\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The conference’s focus on cancer registration, research, data standards and evidence-informed decision-making aligns with the broader need for coordinated approaches to cancer prevention and control across the region.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">As a statutory body established under the Cancer Prevention and Control Act, No. 15 of 2012, NCI-K is mandated to spearhead and coordinate cancer prevention and control in Kenya through the implementation of the National Cancer Control Strategy.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Engagement in regional and international platforms enables the Institute to participate in scientific discussions, strengthen professional networks and contribute to collective efforts to improve cancer information systems and public health responses.\u003C/p>\n\n\n\n\u003Cfigure class=\"wp-block-image size-large\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"683\" src=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/10/818757-1024x683.jpg\" alt=\"\" class=\"wp-image-743\" srcset=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/10/818757-1024x683.jpg 1024w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/10/818757-300x200.jpg 300w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/10/818757-767x512.jpg 767w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/10/818757.jpg 1280w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" />\u003C/figure>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Through continued collaboration with national, regional and international stakeholders, NCI-K remains committed to advancing evidence-informed cancer control and supporting efforts towards a cancer-free nation.\u003C/p>\n\n\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003C/p>\n",false,{"rendered":20,"protected":18},"",1,0,"closed","standard",{"pagelayer_contact_templates":26,"_pagelayer_content":20,"footnotes":20},[],[21],[],[30,12,31,32,33,34,35],"post-739","type-post","status-publish","format-standard","hentry","category-uncategorized",null,{"self":38,"collection":44,"about":47,"author":50,"replies":54,"version-history":57,"predecessor-version":61,"wp:attachment":65,"wp:term":68,"curies":75},[39],{"href":40,"targetHints":41},"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/739",{"allow":42},[43],"GET",[45],{"href":46},"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts",[48],{"href":49},"https://wp.ncikenya.go.ke/wp-json/wp/v2/types/post",[51],{"embeddable":52,"href":53},true,"https://wp.ncikenya.go.ke/wp-json/wp/v2/users/1",[55],{"embeddable":52,"href":56},"https://wp.ncikenya.go.ke/wp-json/wp/v2/comments?post=739",[58],{"count":59,"href":60},3,"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/739/revisions",[62],{"id":63,"href":64},748,"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/739/revisions/748",[66],{"href":67},"https://wp.ncikenya.go.ke/wp-json/wp/v2/media?parent=739",[69,72],{"taxonomy":70,"embeddable":52,"href":71},"category","https://wp.ncikenya.go.ke/wp-json/wp/v2/categories?post=739",{"taxonomy":73,"embeddable":52,"href":74},"post_tag","https://wp.ncikenya.go.ke/wp-json/wp/v2/tags?post=739",[76],{"name":77,"href":78,"templated":52},"wp","https://api.w.org/{rel}",[80,138,196],{"id":81,"date":82,"date_gmt":82,"guid":83,"modified":82,"modified_gmt":82,"slug":85,"status":11,"type":12,"link":86,"title":87,"content":89,"excerpt":91,"author":21,"featured_media":93,"comment_status":94,"ping_status":94,"sticky":18,"template":20,"format":24,"meta":95,"categories":97,"tags":98,"class_list":99,"featured_media_src_url":102,"_links":103},694,"2026-07-09T13:26:16",{"rendered":84},"https://wp.ncikenya.go.ke/?p=694","parliamentary-health-committee-commends-nci-ks-progress-pledges-support-to-strengthen-cancer-control-in-kenya","https://wp.ncikenya.go.ke/2026/07/09/parliamentary-health-committee-commends-nci-ks-progress-pledges-support-to-strengthen-cancer-control-in-kenya/",{"rendered":88},"Parliamentary Health Committee Commends NCI-K’s Progress, Pledges Support to Strengthen Cancer Control in Kenya",{"rendered":90,"protected":18},"\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Nairobi, July 19, 2026\u003C/strong> – The National Assembly Departmental Committee on Health today paid a familiarization and oversight visit to the National Cancer Institute of Kenya (NCI-K) headquarters in Upper Hill, Nairobi, where Members of Parliament received a comprehensive briefing on the state of cancer in Kenya, the Institute’s achievements, and the implementation of the National Cancer Control Strategy 2023–2027.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The Committee, led by its Chairperson, \u003Cstrong>Hon. Dr. James Nyikal\u003C/strong>, was received by the Chairperson of the NCI-K Board of Trustees, \u003Cstrong>Dr. Timothy Olweny\u003C/strong>, and the Chief Executive Officer, \u003Cstrong>Dr. Elias Melly\u003C/strong>, alongside members of the Institute’s management team.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">During the engagement, the Committee was taken through Kenya’s current cancer burden, highlighting the latest \u003Cstrong>GLOBOCAN 2024\u003C/strong> estimates, which indicate \u003Cstrong>35,865 new cancer cases\u003C/strong> and \u003Cstrong>22,888 cancer-related deaths\u003C/strong> annually. The discussion highlighted the growing need for sustained investments in cancer prevention, early detection, treatment, palliative care, research, and surveillance to address the increasing burden of the disease effectively.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The Committee also received an overview of the Institute’s mandate, key milestones, and the progress made in implementing the \u003Cstrong>five strategic pillars of the National Cancer Control Strategy 2023–2027\u003C/strong>, which guide Kenya’s response to cancer through prevention, early detection, diagnosis and treatment, palliative care, governance, research, surveillance, and resource mobilization.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Presenting the Institute’s status, \u003Cstrong>Dr. Elias Melly\u003C/strong> acknowledged the significant progress made despite resource constraints. He noted that NCI-K has continued to coordinate national cancer control programmes, strengthen partnerships, enhance cancer awareness, support county governments, improve cancer surveillance systems, and advance research and policy development.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">However, the CEO emphasized that \u003Cstrong>insufficient funding remains the single greatest challenge\u003C/strong> affecting the full implementation of the National Cancer Control Strategy and the \u003Cstrong>Cancer Prevention and Control Act, 2012\u003C/strong>.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">“While the Institute has achieved remarkable milestones with the limited resources available, adequate and sustainable funding is essential for us to fully implement our statutory mandate and deliver comprehensive cancer control interventions across the country,” Dr. Melly noted.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Members of the Committee commended the Institute for the notable achievements realized despite financial constraints, observing that the progress demonstrates prudent utilization of the resources allocated to NCI-K. They acknowledged the Institute’s growing impact in coordinating the national cancer control agenda and pledged to engage relevant government agencies to address the budgetary challenges affecting its operations.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The Committee further stressed the importance of strengthening cancer research as a key pillar in reducing the country’s cancer burden. \u003Cstrong>Hon. Dr. Robert Pukose\u003C/strong>, Member of Parliament for Endebess Constituency, emphasized that increased investment in research is critical to generating evidence that informs cancer prevention, early detection, diagnosis, treatment, and policy decisions. He called for enhanced funding to enable the Institute to establish and sustain robust cancer research programmes, a position that received unanimous support from the Committee members.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The meeting also explored the management of Regional Cancer Centres across the country. \u003Cstrong>Hon. Pauline Lenguris\u003C/strong>, Woman Representative for Samburu County, raised the need to strengthen the governance and coordination of these centres and proposed that their management be placed under the National Cancer Institute of Kenya to promote uniform standards, enhance coordination, and improve service delivery nationwide. The Committee noted the proposal for further consideration as part of ongoing discussions on strengthening cancer care systems.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">In his remarks, \u003Cstrong>Dr. Timothy Olweny\u003C/strong>, Chairperson of the NCI-K Board of Trustees, thanked the Parliamentary Health Committee for its continued support and oversight, noting that Parliament plays a critical role in creating an enabling environment for effective cancer control through legislation, policy support, and adequate resource allocation.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The visit reaffirmed the shared commitment between Parliament and the National Cancer Institute of Kenya to strengthen the country’s cancer response through increased investment, strategic partnerships, research, and sustainable financing. The Institute remains committed to working closely with Parliament, the Ministry of Health, county governments, development partners, and other stakeholders to accelerate the implementation of the National Cancer Control Strategy and improve cancer outcomes for all Kenyans.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003C/p>\n",{"rendered":92,"protected":18},"\u003Cp>Nairobi, July 19, 2026 – The National Assembly Departmental Committee on Health today paid a familiarization and oversight visit to the National Cancer Institute of Kenya (NCI-K) headquarters in Upper Hill, Nairobi, where Members of Parliament received a comprehensive briefing on the state of cancer in Kenya, the Institute’s achievements, and the implementation of the […]\u003C/p>\n",695,"open",{"pagelayer_contact_templates":96,"_pagelayer_content":20,"footnotes":20},[],[21],[],[100,12,31,32,33,101,34,35],"post-694","has-post-thumbnail","https://wp.ncikenya.go.ke/wp-content/uploads/2026/07/DSC_2379-1024x683.jpg",{"self":104,"collection":109,"about":111,"author":113,"replies":115,"version-history":118,"predecessor-version":121,"wp:featuredmedia":125,"wp:attachment":128,"wp:term":131,"curies":136},[105],{"href":106,"targetHints":107},"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/694",{"allow":108},[43],[110],{"href":46},[112],{"href":49},[114],{"embeddable":52,"href":53},[116],{"embeddable":52,"href":117},"https://wp.ncikenya.go.ke/wp-json/wp/v2/comments?post=694",[119],{"count":21,"href":120},"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/694/revisions",[122],{"id":123,"href":124},696,"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/694/revisions/696",[126],{"embeddable":52,"href":127},"https://wp.ncikenya.go.ke/wp-json/wp/v2/media/695",[129],{"href":130},"https://wp.ncikenya.go.ke/wp-json/wp/v2/media?parent=694",[132,134],{"taxonomy":70,"embeddable":52,"href":133},"https://wp.ncikenya.go.ke/wp-json/wp/v2/categories?post=694",{"taxonomy":73,"embeddable":52,"href":135},"https://wp.ncikenya.go.ke/wp-json/wp/v2/tags?post=694",[137],{"name":77,"href":78,"templated":52},{"id":139,"date":140,"date_gmt":140,"guid":141,"modified":140,"modified_gmt":140,"slug":143,"status":11,"type":12,"link":144,"title":145,"content":147,"excerpt":149,"author":21,"featured_media":151,"comment_status":94,"ping_status":94,"sticky":18,"template":20,"format":24,"meta":152,"categories":154,"tags":156,"class_list":157,"featured_media_src_url":160,"_links":161},697,"2026-07-10T06:36:34",{"rendered":142},"https://wp.ncikenya.go.ke/?p=697","kenya-records-35867-new-cancer-cases-in-latest-globocan-2024-estimates","https://wp.ncikenya.go.ke/2026/07/10/kenya-records-35867-new-cancer-cases-in-latest-globocan-2024-estimates/",{"rendered":146},"Kenya Records 35,867 New Cancer Cases in Latest GLOBOCAN 2024 Estimates",{"rendered":148,"protected":18},"\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Nairobi, Kenya – The latest Global Cancer Observatory (GLOBOCAN) 2024 estimates indicate that 35,867 new cancer cases are diagnosed annually in Kenya, while 22,888 people die from the disease each year. The report also estimates that 76,165 people are living with cancer within five years of diagnosis. Compared to the GLOBOCAN 2022 estimates, the 2024 report reflects lower estimated numbers of new cancer cases, cancer-related deaths, and five-year prevalence. However, cancer remains a significant public health challenge, stressing the need for sustained investment in prevention, early detection, diagnosis, treatment, research, and palliative care.\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>According to the report, breast cancer remains the most commonly diagnosed cancer in Kenya, accounting for 5,822 new cases (16.2%), followed by cervical cancer with 4,294 cases (12.0%), prostate cancer with 3,601 cases (10.0%), oesophageal cancer with 2,532 cases (7.1%), and colorectal cancer with 2,525 cases (7.0%).\u003C/strong>\u003C/p>\n\n\n\n\u003Cfigure class=\"wp-block-image size-large\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"439\" src=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/07/2024-globocan1-1024x439.png\" alt=\"\" class=\"wp-image-699\" srcset=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/07/2024-globocan1-1024x439.png 1024w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/07/2024-globocan1-300x129.png 300w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/07/2024-globocan1-768x330.png 768w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/07/2024-globocan1-1536x659.png 1536w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/07/2024-globocan1.png 1871w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" />\u003C/figure>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>The report also highlights the leading causes of cancer-related deaths. Breast cancer remains the leading cause of cancer mortality, claiming 2,882 lives annually, followed by cervical cancer (2,606 deaths), oesophageal cancer (2,353 deaths), prostate cancer (2,199 deaths), and colorectal cancer (1,481 deaths).\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Among men, prostate cancer continues to be the most commonly diagnosed cancer, accounting for 3,601 new cases (25.9%), followed by oesophageal, colorectal, stomach, and leukaemia. Among women, breast cancer remains the leading cancer with 5,822 new cases (26.5%), followed by cervical cancer, colorectal cancer, oesophageal cancer, and ovarian cancer.\u003C/strong>\u003C/p>\n\n\n\n\u003Cfigure class=\"wp-block-image size-large\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"495\" src=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/07/2024-globocan2-1024x495.png\" alt=\"\" class=\"wp-image-698\" srcset=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/07/2024-globocan2-1024x495.png 1024w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/07/2024-globocan2-300x145.png 300w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/07/2024-globocan2-768x371.png 768w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/07/2024-globocan2-1536x742.png 1536w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/07/2024-globocan2.png 1674w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" />\u003C/figure>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>The findings reaffirm the urgent need to strengthen Kenya’s cancer control efforts through enhanced public awareness, timely screening, early diagnosis, equitable access to quality treatment, palliative care, and sustained investment in cancer research. Early detection remains one of the most effective strategies for improving survival rates and reducing cancer-related deaths.\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>The National Cancer Institute of Kenya (NCI-K) continues to coordinate the implementation of the National Cancer Control Strategy 2023–2027, which provides a comprehensive framework for reducing the country’s cancer burden through five strategic pillars: cancer prevention and early detection; diagnosis, treatment and palliative care; governance and financing; cancer registration, surveillance and research; and monitoring, evaluation, and strategic information.\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>While Kenya has made significant progress in expanding access to cancer services, strengthening county cancer programmes, improving cancer surveillance, and fostering strategic partnerships, the latest GLOBOCAN estimates demonstrate that cancer remains a major public health challenge requiring increased investment and a whole-of-society response.\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>NCI-K calls upon all Kenyans to prioritize healthy lifestyles, participate in recommended cancer screening programmes, seek medical attention promptly for persistent symptoms, and support national efforts aimed at reducing the burden of cancer. The Institute also urges continued collaboration among government, county governments, healthcare providers, development partners, academia, the private sector, and communities to accelerate progress towards a future where fewer Kenyans are diagnosed with cancer and more survive the disease.\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>The GLOBOCAN 2024 estimates, published by the International Agency for Research on Cancer (IARC), provide the latest global and country-specific cancer incidence and mortality statistics and serve as an important resource for informing cancer control planning, policy development, and resource allocation.\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003C/p>\n",{"rendered":150,"protected":18},"\u003Cp>Nairobi, Kenya – The latest Global Cancer Observatory (GLOBOCAN) 2024 estimates indicate that 35,867 new cancer cases are diagnosed annually in Kenya, while 22,888 people die from the disease each year. The report also estimates that 76,165 people are living with cancer within five years of diagnosis. Compared to the GLOBOCAN 2022 estimates, the 2024 […]\u003C/p>\n",699,{"pagelayer_contact_templates":153,"_pagelayer_content":20,"footnotes":20},[],[155],4,[],[158,12,31,32,33,101,34,159],"post-697","category-news-updates","https://wp.ncikenya.go.ke/wp-content/uploads/2026/07/2024-globocan1-1024x439.png",{"self":162,"collection":167,"about":169,"author":171,"replies":173,"version-history":176,"predecessor-version":179,"wp:featuredmedia":183,"wp:attachment":186,"wp:term":189,"curies":194},[163],{"href":164,"targetHints":165},"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/697",{"allow":166},[43],[168],{"href":46},[170],{"href":49},[172],{"embeddable":52,"href":53},[174],{"embeddable":52,"href":175},"https://wp.ncikenya.go.ke/wp-json/wp/v2/comments?post=697",[177],{"count":21,"href":178},"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/697/revisions",[180],{"id":181,"href":182},700,"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/697/revisions/700",[184],{"embeddable":52,"href":185},"https://wp.ncikenya.go.ke/wp-json/wp/v2/media/699",[187],{"href":188},"https://wp.ncikenya.go.ke/wp-json/wp/v2/media?parent=697",[190,192],{"taxonomy":70,"embeddable":52,"href":191},"https://wp.ncikenya.go.ke/wp-json/wp/v2/categories?post=697",{"taxonomy":73,"embeddable":52,"href":193},"https://wp.ncikenya.go.ke/wp-json/wp/v2/tags?post=697",[195],{"name":77,"href":78,"templated":52},{"id":197,"date":198,"date_gmt":198,"guid":199,"modified":198,"modified_gmt":198,"slug":201,"status":11,"type":12,"link":202,"title":203,"content":205,"excerpt":207,"author":21,"featured_media":22,"comment_status":94,"ping_status":94,"sticky":18,"template":20,"format":24,"meta":208,"categories":210,"tags":211,"class_list":212,"featured_media_src_url":36,"_links":214},701,"2026-08-14T13:52:50",{"rendered":200},"https://wp.ncikenya.go.ke/?p=701","the-nci-k-frequently-asked-questions","https://wp.ncikenya.go.ke/2026/08/14/the-nci-k-frequently-asked-questions/",{"rendered":204},"THE NCI-K FREQUENTLY ASKED QUESTIONS",{"rendered":206,"protected":18},"\n\u003Cdiv data-wp-interactive=\"core/file\" class=\"wp-block-file\">\u003Cobject data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/08/FREQUENTLY-ASKED-QUESTIONS.pdf\" type=\"application/pdf\" style=\"width:100%;height:600px\" aria-label=\"Embed of FREQUENTLY ASKED QUESTIONS.\">\u003C/object>\u003Ca id=\"wp-block-file--media-f588684c-c8b2-4c62-b33a-0be4d748438d\" href=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/08/FREQUENTLY-ASKED-QUESTIONS.pdf\">FREQUENTLY ASKED QUESTIONS\u003C/a>\u003Ca href=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/08/FREQUENTLY-ASKED-QUESTIONS.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-f588684c-c8b2-4c62-b33a-0be4d748438d\">Download\u003C/a>\u003C/div>\n",{"rendered":20,"protected":18},{"pagelayer_contact_templates":209,"_pagelayer_content":20,"footnotes":20},[],[21],[],[213,12,31,32,33,34,35],"post-701",{"self":215,"collection":220,"about":222,"author":224,"replies":226,"version-history":229,"predecessor-version":232,"wp:attachment":236,"wp:term":239,"curies":244},[216],{"href":217,"targetHints":218},"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/701",{"allow":219},[43],[221],{"href":46},[223],{"href":49},[225],{"embeddable":52,"href":53},[227],{"embeddable":52,"href":228},"https://wp.ncikenya.go.ke/wp-json/wp/v2/comments?post=701",[230],{"count":21,"href":231},"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/701/revisions",[233],{"id":234,"href":235},703,"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/701/revisions/703",[237],{"href":238},"https://wp.ncikenya.go.ke/wp-json/wp/v2/media?parent=701",[240,242],{"taxonomy":70,"embeddable":52,"href":241},"https://wp.ncikenya.go.ke/wp-json/wp/v2/categories?post=701",{"taxonomy":73,"embeddable":52,"href":243},"https://wp.ncikenya.go.ke/wp-json/wp/v2/tags?post=701",[245],{"name":77,"href":78,"templated":52},1792672535702]